Clinical Trial Detail

Childhood Cancer Survivor Study

Complete title: CHMC-M002: Childhood Cancer Survivor Study (IRB# 11257)

Research Study Number	CHMC-M002
Principal Investigator	K. Scott Baker
Phase	N/A

Look up trial at NIH

Research Study Description

The Childhood Cancer Survivor Study (CCSS) will investigate the long-term effects of cancer and its associated therapies. A retrospective cohort study will be conducted through a multi-institutional collaboration, which will involve the identification and active follow-up of a cohort of approximately 50,000 survivors of cancer, diagnosed before 21 years of age, between 1970 and 1999 and 10,000 sibling controls. This project will study children and young adults exposed to specific therapeutic modalities, including radiation, chemotherapy, and/or surgery, who are at increased risk of late-occurring adverse health outcomes. A group of sibling controls will be identified and data collected for comparison purposes.

Eligibility Criteria (must meet the following to participate in this study)

** For Eligibility information, please click on the "Look up trial at NIH" link above. **

Other eligibility criteria may apply.

Research Study Number	CHMC-M002
Contact	Sarah Fanizzi
Telephone	206/884-1149
E-mail

Keywords: Bone Cancer; Central Nervous System (CNS); Hematologic Malignancies; Kidney Cancer; Leukemia; Lymphoma; Pediatric Cancers, Miscellaneous; Neuroblastoma; Sarcoma; Solid Tumors; Wilms' Tumor; Neoplasms; Rhabdomyosarcoma; Sarcoma, Soft Tissue

Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.

Please remember:

Talk to your health care providers first before making decisions about your health care.

Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each study.

RSS feed

Last Modified, June 25, 2019